Telemus Capital’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-140
Closed -$2K 449
2017
Q4
$2K Buy
+140
New +$2K ﹤0.01% 577